Please use this identifier to cite or link to this item:
|Type:||Artigo de periódico|
|Title:||MYOCARDIAL FIBROSIS IS UNALTERED BY LONG-TERM ADMINISTRATION OF L-ARGININE IN DYSTROPHIN DEFICIENT MDX MICE: A HISTOMORPHOMETRIC ANALYSIS|
|Abstract:||Cardiac failure secondary to myocardial fibrosis (MF) significantly contributes to death in Duchenne muscular dystrophy (DMD), a fatal form of muscle disease. In aging, the mdx mice, an animal model of DMD, MF is similar to that observed in humans. Nitric oxide-based therapy has been proposed to retard MF in DMD and a candidate is L-arginine (L-arg). In this study we evaluated the effects of long-term therapy with L-arg in the MF of mdx mice. Mdx mice (6 months old) were treated with L-arg in drinking water. Control mdx mice received water only. After 15 months of treatment, hearts were stained with Masson's trichrome for analysis of MF and with hematoxilyn and eosin for analysis of inflammation and cardiomyocyte damage. We observed that MF was not affected (29.5+/-2.5% of MF area for control vs 31.4+/-2% for L-arginine-treated animals; P>0.05). The density of inflammatory cells was reduced (169+/-12 cells/mm(2) in control vs 102 +/- 9 cells/mm2 in L-arg-treated; P<0.05). The present study shows that long-term administration of L-arg is not effective in retarding MF in mdx dystrophinopathy.|
Duchenne muscular dystrophy
|Editor:||Akademiai Kiado Rt|
|Appears in Collections:||Unicamp - Artigos e Outros Documentos|
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.